Key result
Continuous hypertonic saline infusion was associated with better Glasgow Coma Scale scores at discharge but did not reduce 30-day all-cause mortality in patients with moderate to severe traumatic brain injury.
Why the study?
Intracranial pressure control is an important requirement for traumatic brain injury patients, but the long-term effect of hypertonic saline remains unknown.
Does continuous hypertonic saline infusion improve clinical outcomes in patients with moderate to severe traumatic brain injury?
Cohort (n=1,955)
Yes
Does continuous hypertonic saline infusion improve clinical outcomes in patients with moderate to severe traumatic brain injury?
Answers are grounded in this paper and cite their sources.
Continuous hypertonic saline infusion in moderate to severe TBI patients does not reduce mortality but may improve neurological outcomes at the cost of increased infection risk and longer ICU stays.
Purpose: Intracranial pressure (ICP) control has long been recognized as an important requirement for traumatic brain injury (TBI) patients. Nevertheless, the long-term effect of hypertonic saline (HTS) remains unknown. The aim of this study was to elucidate the effect on clinical outcomes in TBI patients admitted to intensive care unit (ICU) settings.Methods: We retrospectively identified moderate to severe TBI patients from two public databases named Medical Information Mart for the Intensive Care (MIMIC)-IV and eICU Collaborative Research Database (eICU-CRD). A marginal structural Cox model (MSCM) was used, with time-dependent variates designed to reflect exposure over time during the ICU stay. A trajectory modeling, based on intracranial pressure evolution pattern, allowed identification of subgroups. Results: Overall, in our cohort of 1955 eligible patients, 130 (6.65%) received HTS. MSCM indicated that the HTS was significantly associated with better Glasgow coma score [(GCS): hazard ratio (HR) 1.19, 95% confidence interval (95% CI) 1.01-1.40, p = 0.041], higher infection complications [eg. urinary tract infection (HR 1.88, 95% CI 1.26-2.81, p = 0.002)], and increased ICU LOS (HR 2.02, 95% CI 1.71-2.40, p < 0.001). A protective effect from GCS by the HTS was found in the subgroup with medium and low ICP. Conclusion: Our study revealed no significant difference in the all-cause mortality rates between patients receiving HTS or not. Increased occurrence rates of infection and electrolyte imbalance were inevitable outcomes caused by continuous HTS infusion. Although the study suggested the slight beneficial effects including better neurological outcome, the results warrant further validation.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2021) conducted a cohort in Moderate to severe traumatic brain injury (msTBI) (n=1,955). Continuous hypertonic saline (HTS) infusion vs. No continuous HTS infusion was evaluated on Glasgow Coma Score (GCS) value on the day of discharge (HR 1.19, 95% CI 1.01-1.40, p=0.041). Continuous hypertonic saline infusion was associated with better Glasgow Coma Scale scores at discharge but did not reduce 30-day all-cause mortality in patients with moderate to severe traumatic brain injury.